Rapid assessment of vaccine potency: How automation can help

BioProcess International

Volumn 7, Issue 10, 2009, Pages 52-55

  Smith, Martin ^a  

^a Beacon House   (United Kingdom)

Author keywords

Automation; Clinical trials; OPK assay; Viral plaque assay

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

AUTOMATION; BACTERIAL COUNT; BACTERIUM COLONY; CLINICAL TRIAL; DRUG DETERMINATION; DRUG EFFICACY; DRUG POTENCY; DRUG QUALITY; HUMAN; IMMUNODIFFUSION; NONHUMAN; PHAGOCYTOSIS; PNEUMOCOCCAL INFECTION; SHORT SURVEY; STAPHYLOCOCCUS; VIRUS INHIBITION;

EID: 77953379522     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Short Survey

References (6)

1. Global Vaccine Market Outlook (2007- 2010). RNCOS E-Services Pvt. Ltd.: Delhi, India, November 2007; www.rncos.com/Report/ IM522.htm.
2. Kim KH, Yu J, Nahm M. Efficiency of a Pneumococcal Opsonophagocytic Killing Assay Improved By Multiplexing and By Coloring Colonies. Clin. Diagn. Lab. Immunol. 10, 2003: 616-621.
3. Nahm MH, Briles DE, Yu X. Development of a Multi-Specificity Opsonophagocytic Killing Assay. Vaccine 18(24) 2000: 2768-2771.
4. Barban V, et al. High Stability of Yellow Fever 17D-204 Vaccine: A 12-Year Retrospective Analysis of Large-Scale Production. Vaccine 25(15) 2007: 2941-2950.
5. Wood JM, et al. Single-Radial- Immunodiffusion Potency Tests of Inactivated Influenza Vaccines for Use in Man and Animals. Dev. Biol. Stand. 64, 1986: 169-177.
6. Wood JM, et al. The Influence of the Host Cell on Standardisation of Influenza Vaccine Potency. Dev. Biol. Stand. 98, 1999: 183-188.